naltrexone has been researched along with ADDH in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Kalin, NH | 1 |
Huang, TS; Lin, CC; Liu, YP; Tung, CS | 1 |
Findling, RL; Ji, NY | 1 |
Clark, DB | 1 |
Pachler, M; Scahill, L | 1 |
Adesman, AR | 1 |
Bernstein, GA; Cook, EH; Leonard, HL; March, JS; Riddle, MA; Swanson, JM | 1 |
Buitelaar, JK; van Berckelaer-Onnes, IA; van Engeland, H; Willemsen-Swinkels, SH | 1 |
Bouvard, M; Klingler, D; Lampl, C; Leboyer, M; Lensing, P; Panksepp, J; Plumet, MH | 1 |
Sloman, L | 1 |
4 review(s) available for naltrexone and ADDH
Article | Year |
---|---|
Pharmacotherapy for mental health problems in people with intellectual disability.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Human Growth Hormone; Humans; Intellectual Disability; Lithium Compounds; Mental Disorders; Methylphenidate; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotropic Drugs; Risperidone | 2016 |
Treatment of hyperactivity in children with pervasive developmental disorders.
Topics: Adrenergic alpha-Agonists; Amantadine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child Psychiatry; Dopamine Agents; Guanfacine; Humans; Methylphenidate; Naltrexone; Narcotic Antagonists; Patient Selection; Treatment Outcome | 2007 |
Anxiolytics, adrenergic agents, and naltrexone.
Topics: Adolescent; Adolescent Psychiatry; Adrenergic Agonists; Anti-Anxiety Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Psychiatry; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Treatment Outcome | 1999 |
Use of medication in pervasive developmental disorders.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Development Disorders, Pervasive; Fenfluramine; Humans; Methylphenidate; Naltrexone; Psychotropic Drugs | 1991 |
1 trial(s) available for naltrexone and ADDH
Article | Year |
---|---|
Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child, Preschool; Female; Humans; Interpersonal Relations; Male; Naltrexone; Social Adjustment | 1999 |
5 other study(ies) available for naltrexone and ADDH
Article | Year |
---|---|
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
Topics: Alcoholism; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Patient Outcome Assessment; Schizophrenia; Smoking; Varenicline | 2021 |
Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Afferent Pathways; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzylamines; Brain; Brain Injuries; Choice Behavior; Impulsive Behavior; Male; Microdialysis; Naltrexone; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Rats; Rats, Sprague-Dawley; Reaction Time; Zimeldine | 2015 |
Pharmacotherapy for adolescent alcohol use disorder.
Topics: Acamprosate; Adolescent; Alcohol-Related Disorders; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Central Nervous System Stimulants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Disulfiram; Humans; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders; Taurine | 2012 |
Hyperactivity and ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Comorbidity; Diagnosis, Differential; Humans; Hyperkinesis; Naltrexone; Narcotic Antagonists | 1996 |
Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child, Preschool; Humans; Intellectual Disability; Male; Naltrexone; Personality Assessment; Social Behavior | 1992 |